HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maija Dambrova Selected Research

Apolipoproteins E (ApoE)

9/2015Methyl-γ-butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis.
1/2009Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maija Dambrova Research Topics

Disease

12Infarction (Infarctions)
12/2023 - 06/2002
12Ischemia
12/2023 - 06/2002
7Insulin Resistance
03/2022 - 11/2016
7Inflammation (Inflammations)
12/2021 - 12/2005
7Type 2 Diabetes Mellitus (MODY)
12/2020 - 08/2009
6Reperfusion Injury
12/2023 - 08/2009
6Hypoxia (Hypoxemia)
12/2023 - 01/2014
5Seizures (Absence Seizure)
01/2023 - 09/2010
5Myocardial Infarction
01/2021 - 08/2009
5Atherosclerosis
11/2016 - 01/2009
5Encephalitis (Encephalitis, Rasmussen)
04/2010 - 12/2005
4Pain (Aches)
03/2021 - 10/2006
4Hyperglycemia
01/2021 - 05/2011
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 11/2014
4Diabetes Complications
02/2013 - 08/2009
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2023 - 09/2011
3Mitochondrial Diseases (Mitochondrial Disease)
12/2020 - 02/2017
3Heart Failure
12/2020 - 11/2016
3Necrosis
10/2020 - 08/2009
3Body Weight (Weight, Body)
01/2020 - 12/2007
3Cardiac Arrhythmias (Arrythmia)
11/2016 - 06/2002
2Neuroinflammatory Diseases
01/2024 - 01/2004
2Traumatic Brain Injuries (Traumatic Brain Injury)
10/2021 - 01/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 01/2017
2Hyperlipidemias (Hyperlipidemia)
12/2020 - 05/2011
2Glucose Intolerance
09/2017 - 05/2011
2Obesity
01/2017 - 05/2011
2Weight Gain
01/2017 - 05/2011
2Brain Ischemia (Cerebral Ischemia)
11/2016 - 09/2011
2Atherosclerotic Plaque (Atheroma)
09/2015 - 01/2009
2Hypertension (High Blood Pressure)
01/2014 - 01/2011
2Coronary Occlusion
08/2009 - 06/2002
1Liver Failure
04/2024
1Fatigue
01/2024
1Post-Acute COVID-19 Syndrome
01/2024
1Stomach Neoplasms (Stomach Cancer)
04/2023
1Neoplasms (Cancer)
04/2023
1Thyroid Diseases (Thyroid Disease)
01/2023
1Autism Spectrum Disorder
01/2023
1Reflex Epilepsy (Photosensitive Epilepsy)
01/2023
1Brain Diseases (Brain Disorder)
01/2023
1Epilepsy (Aura)
01/2023
1Mental Disorders (Mental Disorder)
07/2022
1Anhedonia
07/2022
1Adenocarcinoma
01/2022
1Hypertrophy
12/2021
1Pulmonary Hypertension
12/2021
1Ventricular Dysfunction
12/2021
1Left Ventricular Dysfunction
12/2021
1COVID-19
12/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2021

Drug/Important Bio-Agent (IBA)

16Carnitine (L-Carnitine)FDA LinkGeneric
04/2023 - 12/2006
143-(2,2,2-trimethylhydrazine)propionateIBA
12/2021 - 08/2002
12Fatty Acids (Saturated Fatty Acids)IBA
04/2024 - 08/2009
10Glucose (Dextrose)FDA LinkGeneric
04/2024 - 08/2009
9acylcarnitineIBA
12/2023 - 09/2015
8trimethyloxamine (trimethylamine N-oxide)IBA
04/2023 - 10/2013
54-amino-3-phenylbutyric acid (phenibut)IBA
09/2020 - 03/2008
5MelanocortinsIBA
01/2010 - 01/2004
4methyl-gamma-butyrobetaineIBA
12/2023 - 09/2015
4Sigma-1 ReceptorIBA
01/2023 - 01/2017
4LigandsIBA
01/2023 - 01/2010
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2017
4Insulin (Novolin)FDA Link
06/2021 - 01/2014
4Peptides (Polypeptides)IBA
01/2020 - 01/2004
4Blood Glucose (Blood Sugar)IBA
01/2017 - 08/2009
4Melanocortin Receptors (Melanocortin Receptor)IBA
01/2010 - 12/2005
3gamma-butyrobetaine (butyrobetaine)IBA
04/2023 - 12/2006
3Pyruvic Acid (Pyruvate)IBA
01/2021 - 10/2020
3SaltsIBA
12/2020 - 08/2009
3LipopolysaccharidesIBA
10/2020 - 12/2007
31- (3,4- dimethoxy- 2- - chlorobenzylideneamino)guanidineIBA
04/2010 - 06/2002
3Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2010 - 06/2006
2Neuroprotective AgentsIBA
10/2021 - 11/2016
2Pentylenetetrazole (Metrazol)IBA
01/2021 - 10/2015
2imidazole mustard (BIC)IBA
01/2021 - 01/2017
2LipidsIBA
12/2020 - 01/2019
2Interleukin-1beta (Interleukin 1 beta)IBA
10/2020 - 04/2010
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2020 - 04/2010
2Metformin (Glucophage)FDA LinkGeneric
01/2020 - 05/2011
2Dizocilpine Maleate (Dizocilpine)IBA
12/2019 - 10/2019
2PalmitoylcarnitineIBA
09/2017 - 01/2016
2Apolipoproteins E (ApoE)IBA
09/2015 - 01/2009
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2013 - 06/2012
2EnzymesIBA
05/2013 - 03/2011
2NF-kappa B (NF-kB)IBA
04/2010 - 12/2005
2beta-MSHIBA
10/2006 - 12/2005
2Guanidine (Guanidine Nitrate)FDA Link
08/2004 - 06/2002
1Acetylcarnitine (Alcar)IBA
01/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023
1triphenyltetrazoliumIBA
12/2023
1SeleniumIBA
01/2023
1trimethyl-lysine hydroxylaseIBA
01/2023
1Sucrose (Saccharose)IBA
07/2022
1C-PeptideIBA
03/2022
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2022
1Ketone BodiesIBA
03/2022
1CytokinesIBA
03/2021

Therapy/Procedure

3Therapeutics
01/2023 - 01/2020
1Traditional Medicine (Folk Remedies)
03/2021